Calendario de promoción SAB Biotherapeutics, Inc.
Horario avanzado
gráfico sencillo
Acerca de la empresa
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases. Más detallesВыручка | 0.0034 |
---|---|
EBITDA | -0.0082 |
Число акций ао | 0.00552 млрд |
P/S | 0.3507 |
P/BV | 0.5539 |
EV/EBITDA | -0.1569 |
Цена ао | 4.17 |
ISIN | US78397T1034 |
Сайт | https://www.sabbiotherapeutics.com |
Валюта | usd |
IPO date | 2021-02-09 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
Cambio de precio por día: | -5.02% (2.5899) |
---|---|
Cambio de precio por semana.: | -7.87% (2.67) |
Cambio de precio por mes: | -12.77% (2.82) |
Cambio de precio en 3 meses.: | -14.29% (2.87) |
Cambio de precio en seis meses: | -44.84% (4.46) |
Cambio de precio por año: | +260.7% (0.682) |
Cambio de precio en 3 años.: | -75.57% (10.07) |
Cambio de precio desde principios de año.: | +170.33% (0.91) |
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
Instituciones | Volumen | Compartir, % |
---|---|---|
Marshall Wace LLP | 4585282 | 49.7 |
RA Capital Management, L.P. | 2374081 | 25.73 |
COMMODORE CAPITAL LP | 1831746 | 19.86 |
RTW Investments LP | 917828 | 9.95 |
BVF Inc. | 917828 | 9.95 |
Sessa Capital IM, L.P. | 458457 | 4.97 |
Vanguard Group Inc | 99614 | 1.08 |
First Premier Bank | 80754 | 0.88 |
Pathstone Holdings, LLC | 50651 | 0.55 |
Geode Capital Management, LLC | 35636 | 0.39 |
ETF | Compartir, % | Rentabilidad del año, % | Dividendos, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.00541 | 43.316995205115 | 1.54048 |
Supervisor | Título profesional | Pago | año de nacimiento |
---|---|---|---|
Mr. Samuel J. Reich | CEO & Executive Chairman | 363.2k | 1975 (49 años) |
Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director | 402.56k | 1966 (58 años) |
Ms. Christine E. Hamilton M.B.A. | Co-Founder & Independent Director | 25k | 1956 (68 años) |
Dr. Alexandra Kropotova M.B.A., M.D. | Executive VP & Chief Medical Officer | 774.45k | 1973 (51 año) |
Dr. Edward D. Hamilton D.V.M. | Co-Founder & Board Observer | N/A | |
Dr. Christoph Bausch M.B.A., Ph.D. | Executive VP & COO | 443.2k | 1971 (53 año) |
Dr. Carlos N. Carillo Ph.D. | Senior Vice President of Regulatory Affairs | N/A | |
Mr. Mark W. Conley | Interim Chief Financial Officer |
DIRECCIÓN: United States, Sioux Falls. SD, 2100 East 54th Street North - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.sabbiotherapeutics.com
Sitio web: https://www.sabbiotherapeutics.com